Indian pharma market grew by 13.7% in July 2021: Ind-Ra
Demand normalisation post the second wave contributed to the steady growth
Demand normalisation post the second wave contributed to the steady growth
Innovative solutions and a deep understanding of the market makes this a unique combination
Riding COVID-19 wave, Indian vaccine industry set to be Rs. 700 billion strong
Essential medicines were made available to more than 150 countries around the world during the pandemic
The resilient attitude of Indian pharmaceutical companies coupled with quick innovative solutions has ensured consistency in supply chains amid unprecedented challenges
The Department has been working continuously to ensure a stable long-term policy environment and reduce the compliance burden on the Industry.
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
Accreditations for Bhayla manufacturing site strengthen the company’s global quality credentials and support expansion of its hormone portfolio into regulated international markets
The accepted studies span several critical areas of oncology, including nutrition, genomics, precision medicine, patient-reported outcomes, and community-based cancer care
Seasoned HR leader brings over 15 years of experience in global talent strategy, organizational transformation, and workforce planning
Subscribe To Our Newsletter & Stay Updated